Applications Published 20 February 2002
Published: 1-Sep-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Niacinamide compsns with reduced tack
Procter & Gamble 1180012*
Local drug delivery
Biocompatibles 1180013*
Injectable anaesthetic formulation
Abbott Laboratories 1180014*
Generation of therapeutic microfoam
BTG International 1180015*
Methods and compsns for non-viral gene therapy for treatment of hyperproliferative diseases
Introgen Therapeutics; Board of Regents, the University of Texas System 1180016*
Preparation for the application of anti-infective and/or anti-inflammatory agents
Euroceltique 1180017*
Antibiotic-natural polysaccharide polymer adducts
Istituto Biochimico Pavese Pharma 1180019*
Porous drug matrices and methods of manufacture thereof
Acusphere 1180020*
Regimen and kit for amelioration of premature ejaculation
Pentech Pharmaceuticals 1190021*
Process for preparing pharmaceutical bulk material having uniform dissolution
Eli Lilly 1180022*
Substrate sections with improved storage stability during their storage in bags, and a method for producing the same
LTS LohmannTherapie-Systeme 1180023*
Z-styryl sulphone anticancer agents
Temple University of the Commonwealth System of Higher Education 1180024*
IL-8 receptor antagonists
SmithKline Beecham 1180025*
Use of 15-deoxysperagualin for the treatment of hyperreactive inflammatory disorders and autoimmune diseases
Euro Nippon Kayaku; Nippon Kayaku 1180026*
Method for the prevention or reduction of cardiovascular events associated with coronary intervention
SmithKline Beecham 1180027*
IL-8 receptor antagonists
SmithKline Beecham 1180028*
Bicyclic acid guanidine sodium/proton exchange inhibitors and method
Bristol-Myers Squibb 1180029*
Antibacterial compounds
SmithKline Beecham, 1180030*
Noscapine derivatives as adjuvant compsns and methods of use thereof
Emory University 1180031*
Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function
Lupin Laboratories 1180032*
Lamivudine containing pharmaceutical formulation
Glaxo Wellcome KK 1180033*
Novel epidermal growth factor receptor-binding compounds for positron emission tomography
Hadasit Medical Research Services & Development; Yissum Research Development Company of the Hebrew University of Jerusalem 1180034*
Non-calcemic, antiproliferative, transcriptionally active sulfur-containing alaogues of 1a, 25-dihydroxy vitamin D3
Johns Hopkins University 1180035*
Cell therapy for chronic stroke
Layton Bioscience 1180036*
Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
The Brigham and Women's Hospital 1180037*
Antifungal combination use
Fujisawa Pharmaceutical 1180038*
Factor for regulation of neurite growth
Oxford Bioscience 1180039*
Methods for treating congestive heart failure
Cambridge Neuroscience; The Brigham and Women's Hospital 1180040*
Vaccine against ISA virus
Genomar 1180041*
Model membrane systems
The Australian National University 1180042*
Multi-stage method for producing gas-filled microcapsules
Schering 1180043*
Resorbable implant
Ethicon 1180044*
Needleless injector drug capsule
Weston Medical 1180046*
Fused polycyclic amino acids as pharmaceutical agents
Warner-Lambert 1180094*
4-cyano-3-hydroxy butanoyl hydrazines, derivatives and processes for the preparation thereof
Michigan State University 1180095*
Mutual salt of amlodipine and atorvastatin
Pfizer Products 1180097*
New compounds
AstraZeneca 1180099*
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
Merck Frost Canada 1180100*
Compounds having cytokine inhibitory activity
Merck 1180101*
Mutual prodrugs of amlodipine and atrovastatin
Pfizer 1180102*
Renin inhibitors
F Hoffmann-La Roche 1180103*
Methods of separating FTC isomers and derivatives thereof
Pharm-Eco Laboratories 1180104*
Substituted aza-oxindole derivatives
Glaxo Group 1180105*
4-substituted milbemycin derivatives
Novartis 1180106*
Novel ruthenium metal alkylidene complexes coordinated with traizolidene ligands that exhibit high olefin metathesis activity
California Institute of Technology 1180107*
